InspireMD, Inc. (NSPR) Free cash flow 2016–2025
InspireMD, Inc. (NSPR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$36.8MFY2025 · since FY2016: -$7.5M → -$36.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$36.8M | -58.0% |
| FY2024 | -$23.3M | -38.9% |
| FY2023 | -$16.8M | -4.6% |
| FY2022 | -$16.0M | -18.2% |
| FY2021 | -$13.6M | -47.8% |
| FY2020 | -$9.2M | +9.2% |
| FY2019 | -$10.1M | -31.6% |
| FY2018 | -$7.7M | +8.5% |
| FY2017 | -$8.4M | -11.2% |
| FY2016 | -$7.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NSPR financial trends
NSPR RevenueNSPR Net incomeNSPR Net marginNSPR Gross profitNSPR Gross marginNSPR Operating incomeNSPR Operating marginNSPR Operating cash flowNSPR Capital expendituresNSPR Return on equityNSPR Stock buybacksNSPR Dividends paidNSPR Total assetsNSPR Total liabilitiesNSPR Shareholders’ equityNSPR overview →